Subscribe
eNewsletter
Ready to get certified?
Free CDCES Coach App
Download
Free Med Pocket Cards
eNewsletter
Free CDCES Coach App
Free Med Pocket Cards
For last week’s practice question, we quizzed participants on BC-ADM exam updates. 55% of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!
Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it by clicking here.
There are going to be big changes in 2027 for those thinking about sitting for their Board Certification in Advanced Diabetes Management (BC-ADM) Exam.
For now, which of the following statements reflects the current qualifications to take the BC-ADM Exam?
Answer A is incorrect. 32.08% chose this answer: “Applicants need to document 1000 hours of advanced diabetes management experience to apply.” To apply for the exam, candidates are only required to document a minimum of 500 clinical practice hours in advanced diabetes management within the 48 months prior to filing the application. The 1,000-hour requirement actually applies to the renewal of the certification every 5 years, not the initial application.
Answer B is correct. 55.26% of you chose this answer, “RN, RPh, RDN’s with a master’s degree or higher are eligible for the exam.” To sit for the Board Certification in Advanced Diabetes Management (BC-ADM) exam, candidates must hold an advanced clinical degree (Master’s degree or higher) in an eligible discipline. Registered Nurses (RN), Registered Pharmacists (RPh), and Registered Dietitian Nutritionists (RDN) with a master’s or doctoral degree meet this primary criteria, assuming they also hold an active, unrestricted license or registration. NP’s, PA’s, DO’s and MD’s are also eligible.
Answer C is incorrect. 3.5% of respondents chose this: “Applicants need to be involved in academics or research to qualify for the exam.” While advanced diabetes management roles can encompass participating in research and mentoring, this is not a mandatory eligibility rule. The core requirement focuses on advanced clinical practice hours (such as adjusting medications, physical assessments, and complex decision-making) rather than pure academic or research involvement.
Finally, Answer D is incorrect. 9.16% chose this answer, “Exercise physiologists and physical therapists are eligible with a special waiver.” The BC-ADM exam specifies discipline tracks that include advanced practice nurses, registered dietitians, pharmacists, physicians, and physician assistants). There is no “special waiver” policy that allows exercise physiologists or physical therapists to bypass the core discipline or advanced degree requirements
Big Changes Coming for BC-ADM in 2027
Considering adding the Board Certification in Advanced Diabetes Management (BC-ADM) to your credentials? With anticipated exam changes in 2027, consider taking the exam in December of 2026. Learn more by clicking heading.
We hope you appreciate this week’s rationale! Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!
Want to Learn More about this Question?
Elevate your career with the BC-ADM credential
The Board Certification in Advanced Diabetes Management (BC-ADM) credential recognizes your clinical expertise and dedication to outstanding diabetes care.
Wondering What the Next Steps Are?
Join Coach Beverly for a FREE, information-packed webinar to map out your journey. Learn strategies to succeed at this mastery-level exam and map out your study journey.
You Asked. We Listened.
Lower Prices on our Top BC-ADM Exam CE Boot Camp
Kick-start your dream of achieving advanced certification starting today. Our evidence-based BC-ADM Boot Camp is designed for healthcare professionals preparing for the Board Certificate in Advanced Diabetes Management exam.
Starting Price: $399
For last week’s practice question, we quizzed participants on HAES®‑aligned philosophy. 96% of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!
Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it by clicking here.
MS is a 27-year-old with type 1 diabetes, hypertension, and dyslipidemia, a body mass index (BMI) of 38, and A1C of 8.1%. During today’s visit they say, “Every appointment seems to focus on my weight. I’m tired of feeling judged, and I’m starting to avoid coming to clinic.”
Which response by the diabetes health care professional is most consistent with the philosophy of Health at Every Size® (HAES®)?
Answer A is incorrect. 2.05% chose this answer, “Stepping on the scale can be scary, but losing even a few pounds will improve all of your health conditions.” This response reinforces a weight-centered approach and does not acknowledge the patient’s feelings of stigma or avoidance of care. While weight loss may improve metabolic health for some individuals, HAES emphasizes that healthcare should not be contingent on achieving a specific body weight and that behavior change can improve health regardless of weight change.
Answer B is correct. 95.89% of you chose this answer, “Let’s put the scale aside for today and focus on what matters most to you.” Great job, this is the BEST answer. The Health at Every Size® (HAES®) approach promotes weight-inclusive, person-centered care that emphasizes health-promoting behaviors rather than weight as the primary measure of success. Core principles include respecting body diversity, reducing weight stigma, supporting intuitive eating and enjoyable physical activity, and partnering with individuals to identify meaningful, achievable health goals. This approach demonstrates these principles by acknowledging the person’s experience, reducing judgment, engaging in shared decision-making, and focusing on sustainable behaviors that support overall health and well-being.
Answer C is incorrect. 0% of respondents chose this: “Weight loss is essential for diabetes management, so let’s review a meal plan that will bring you success.” This answer is incorrect. This response continues to prioritize weight over the patient’s concerns and may increase feelings of shame or disengagement. Current diabetes care emphasizes individualized, person-centered treatment that addresses the patient’s priorities, readiness for change, and quality of life.
Finally, Answer D is incorrect. 2.05% chose this answer, “Since weight discussions are upsetting, let’s avoid talking about nutrition and physical activity during future visits.” HAES does not discourage discussions about healthy eating or physical activity. Instead, it encourages conversations that are free of judgment, focus on health-enhancing behaviors, and support autonomy rather than emphasizing weight loss.
We hope you appreciate this week’s rationale! Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!
Weight stigma is a well-documented barrier to effective diabetes care — contributing to poorer glycemic control, disordered eating, and care avoidance. This course provides healthcare providers with actionable strategies to integrate weight-inclusive care into diabetes management, focusing on improving outcomes through respect for body diversity and individual autonomy. By shifting from a weight-focused approach to one aligned with Health at Every Size (HAES®), providers can foster trust, enhance engagement, and support sustainable health behaviors.
Jessica Jones, MS, RDN, CDCES, shares evidence-based insights on mitigating weight stigma and applying HAES®-aligned strategies in practice. You’ll learn how to build rapport, set realistic nutrition goals, and implement interventions that prioritize blood glucose management, joyful movement, and intuitive eating.
Course Topics:
Explore the unexpected link between cancer and diabetes — and master glucose management strategies for people with diabetes undergoing treatment.
Individuals with cancer often experience hyperglycemia secondary to treatment, which can increase the risk of infection and other complications. Recent research has also identified a significant link between diabetes and cancer. This course uses a case study approach to explore this connection and provide practical strategies for managing steroid-induced hyperglycemia and improving quality of life for people navigating both conditions.
Course Topics:
For last week’s practice question, we quizzed participants on the sudden onset of hyperglycemia. 84% of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!
Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it by clicking here.
A 67-year-old woman with type 2 diabetes (A1C 7.2%) is receiving chemotherapy for metastatic breast cancer. As part of her treatment, she receives high-dose dexamethasone every morning for 3 days following each chemotherapy cycle. She takes metformin and insulin glargine daily. Her fasting glucose values remain between 95–120 mg/dL, but glucose levels increase to 260–320 mg/dL after lunch and dinner on steroid treatment days.
Which intervention is the most appropriate?
Answer A is incorrect. 8.50% chose this answer, “Increase the basal insulin dose by 50% along with metformin dose on chemotherapy days.” Basal insulin primarily targets fasting glucose, which is already within target. An increase in basal insulin may lead to nocturnal or fasting hypoglycemia and will not adequately address post-meal hyperglycemia.
Answer B is incorrect. 2.77% of you chose this answer, “Hold basal insulin and add SGLT2 inhibitor along with the metformin.” This answer is not correct. SGLT2 inhibitors do not provide rapid glucose lowering needed for acute steroid-induced hyperglycemia. Also, stopping the insulin could lead to dangerous blood glucose elevations due to the side effects of chemotherapy including, dehydration, infection, poor oral intake, leading to increased risk of hyperglycemic crisis during treatment periods.
Answer C is incorrect. 4.74% of respondents chose this: “Recommend limiting carbohydrates until chemotherapy is completed.” This answer is incorrect. Restricting carbohydrates excessively during cancer treatment may worsen nutritional status and doesn’t address steroid-induced hyperglycemia. Medication adjustments—not severe dietary restriction—are the treatment of choice.
Finally, Answer D is correct. 83.99% chose this answer, “Use a combination of intermediate-acting and rapid-acting insulin on chemotherapy days.” Great job! You chose the best answer. Glucocorticoids commonly produce postprandial hyperglycemia, particularly in the afternoon and evening after morning dosing. Matching insulin therapy to the steroid’s glycemic effect by using NPH insulin along with bolus mealtime insulin, is generally more effective than simply increasing basal insulin. Continuous glucose monitoring (CGM), when available, can help identify steroid-related glucose patterns.
We hope you appreciate this week’s rationale! Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!
Explore the unexpected link between cancer and diabetes — and master glucose management strategies for people with diabetes undergoing treatment.
Individuals with cancer often experience hyperglycemia secondary to treatment, which can increase the risk of infection and other complications. Recent research has also identified a significant link between diabetes and cancer. This course uses a case study approach to explore this connection and provide practical strategies for managing steroid-induced hyperglycemia and improving quality of life for people navigating both conditions.
Course Topics:
For last week’s practice question, we quizzed participants on the sudden onset of hyperglycemia. 66% of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!
Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it by clicking here.
A 58-year-old man without a history of diabetes is receiving treatment with an immune checkpoint inhibitor for metastatic melanoma. Four months after beginning therapy, he presents with polyuria, weight loss, nausea, and fatigue. Laboratory findings include:
Which mechanism most likely explains this sudden hyperglycemia?
Answer A is incorrect. 9.84% chose this answer, “Progressive insulin resistance caused chronically elevated cortisol levels.” This answer is incorrect. Insulin resistance due to elevated cortisol levels gradually elevates glucose levels and is not usually associated with severe insulin deficiency, undetectable C-peptide, or DKA.
Answer B is correct. 66.14% of you chose this answer, “Autoimmune destruction of pancreatic beta cells.” You chose the best answer. Great Job! Immune checkpoint inhibitors can precipitate rapid-onset autoimmune diabetes, often presenting as diabetic ketoacidosis (DKA). Beta-cell destruction is typically abrupt, resulting in profound insulin deficiency requiring lifelong insulin therapy.
Answer C is incorrect. 19.29% of respondents chose this: “Glucocorticoid-induced hepatic glucose production.” Answer C is incorrect. Although corticosteroids commonly cause hyperglycemia, they generally produce insulin resistance rather than complete beta-cell destruction or absent C-peptide. There is no indication this patient is receiving glucocorticoids.
Finally, Answer D is incorrect. 4.72% chose this answer, “Pancreatic exocrine insufficiency from chronic pancreatitis.” Pancreatitis-related diabetes (type 3c diabetes) usually develops over time and is associated with exocrine pancreatic dysfunction, malabsorption, and a history of pancreatic disease—not sudden autoimmune beta-cell destruction and DKA following immunotherapy.
We hope you appreciate this week’s rationale! Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!
Explore the unexpected link between cancer and diabetes — and master glucose management strategies for people with diabetes undergoing treatment.
Individuals with cancer often experience hyperglycemia secondary to treatment, which can increase the risk of infection and other complications. Recent research has also identified a significant link between diabetes and cancer. This course uses a case study approach to explore this connection and provide practical strategies for managing steroid-induced hyperglycemia and improving quality of life for people navigating both conditions.
Course Topics:
For last week’s practice question, we quizzed participants on diabetes and sleep health. 69% of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!
Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it by clicking here.
SW is a 52-year-old living with type 2 diabetes. Over the past year, A1C increased from 7.1% to 8.2%, and blood pressure during their visit was 146/88 mmHg. They report increased fatigue, daytime sleepiness, difficulty concentrating, and waking up several times during the night. SW works rotating night shifts at a manufacturing plant.
Which of the following responses would best align with the 2026 ADA Standards of Care?.
Answer A is incorrect. 10.96% chose this answer, “Reassure SW that the sleep complaints are a normal consequence of shift work and focus the visit on intensifying glucose-lowering and antihypertensive medications to address the rising A1C and elevated blood pressure.” This answer is incorrect. While intensifying diabetes medications and addressing hypertension are important components of care, dismissing the sleep complaints as simply a normal consequence of shift work does not align with the 2026 ADA Standards of Care. Keep reading for additional recommendations.
Answer B is incorrect. 4.39% of you chose this answer, “Recommend SW take an over-the-counter melatonin supplement nightly, intensify glucose-lowering medications, and schedule a follow-up in 3 months to reassess A1C and blood pressure.” his answer is incorrect. Although sleep is recognized as a key component of diabetes management, the 2026 ADA Standards of Care do not recommend over-the-counter melatonin as a primary intervention for sleep complaints in people with diabetes. SW’s symptoms with excessive daytime sleepiness and frequent nocturnal awakenings warrant evaluation for obstructive sleep apnea (OSA) and other sleep disorders. Untreated OSA contributes to hyperglycemia, insulin resistance, and hypertension through sympathetic nervous system activation.
Answer C is correct. About 69.30% of respondents chose this: “Screen for sleep health and disorders and refer to a sleep medicine specialist or other qualified specialist, as indicated.” Answer C is correct. You chose the best answer. Great Job! This response directly aligns with the 2026 ADA Standards of Care, Section 5 recommendation to screen for sleep health and refer to sleep medicine specialists and/or qualified behavioral health professionals when indicated. SW’s symptoms are consistent with possible OSA, which has a prevalence of approximately 55% in type 2 diabetes, and the combination of worsening A1C and elevated blood pressure may be partly driven by an untreated sleep disorder. Additionally, individuals with diabetes who perform shift work increase their risk for circadian rhythm disorders, which are associated with elevated A1C, neuropathy, and decreased psychological well-being.
Finally, Answer D is incorrect. 15.35% chose this answer, “Discuss with SW the impacts of night shift work, consider changing to a day shift to improve diabetes self-management, A1c and reduce blood pressure.” Answer D is incorrect. While the 2026 ADA Standards of Care acknowledge that shift work increases the risk for circadian rhythm disorders and is associated with elevated A1C, the Standards do not recommend that individuals quit shift work as a prerequisite for diabetes management. Advising a patient to quit their job is neither practical nor evidence-based and does not address the immediate need for sleep disorder screening and management
We hope you appreciate this week’s rationale! Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!
Solve common glucose mysteries and optimize time-in-range for people with type 2 diabetes.
Why are glucose levels elevated in the morning? When should insulin be started? What is the next step to get A1c to target? During this course Coach Beverly addresses each of these glucose mysteries and more, using a person-centered approach. She describes a stepwise approach to evaluate glucose patterns and correct common issues encountered by people living with type 2 diabetes.
Course Topics:
Course Objectives
Upon completion of this activity, participants will be able to:
For last week’s practice question, we quizzed participants on meal skipping and postprandial hyperglycemia. 97% of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!
Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it by clicking here.
A 42-year-old woman with type 2 diabetes presents for follow-up. She reports trying to lose weight by “cutting carbs,” but admits she often skips meals during the day and overeats at night. Current medications include metformin and basal insulin. CGM data shows fasting glucose values within target range, but frequent post-dinner glucose excursions above 240 mg/dL. She asks whether she should continue avoiding carbohydrates altogether.
Which of the following responses by the CDCES is MOST appropriate?
Answer A is incorrect. 1.91% chose this answer, “Recommend eliminating carbohydrates completely to improve glycemic management.” This is not the best answer. Complete carbohydrate elimination is not recommended for most individuals with diabetes. ADA SOC emphasize individualized meal planning and sustainable eating patterns over strict carbohydrate avoidance.
Answer B is correct. 96.65% of you chose this answer, “Encourage balanced meal timing and distribution of carbohydrate intake throughout the day.” Great job! This is the best answer. Current ADA Standards of Care recommendations emphasize individualized meal planning and sustainable eating patterns rather than complete carbohydrate elimination. Skipping meals may contribute to excessive evening hunger and larger postprandial glucose excursions. Supporting balanced meal timing and carbohydrate distribution can improve overall glycemia.
Answer C is incorrect. About 0.96% of respondents chose this: “Advise increasing protein intake only at dinner to prevent glucose excursions.” This is not the best answer. Increasing protein only at dinner does not address the patient’s overall eating pattern or meal timing. High-protein and high-fat meals may also contribute to delayed postprandial hyperglycemia.
Finally, Answer D is incorrect. 0.48% chose this answer, “Recommend avoiding all evening snacks regardless of hunger level.” This is not the best answer. Avoiding all evening snacks is overly restrictive and does not address the likely driver of evening overeating, which is meal skipping earlier in the day. ADA SOC supports individualized, sustainable eating strategies.
We hope you appreciate this week’s rationale! Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!
🌟Updated Schedule: ADA Boot Camp, Tech, MNT & More
Live in Beautiful San Diego – Oct 22-23, 2026
Re-Ignite your Passion & Prepare for Diabetes Certification Exams
🎓 Earn 30+ CEs: AMA PRA Category 1 Credits™, ACPE, ANCC, and CDR!
📅
2-Day Conference
Oct 22–23, 2026
⏱️
15.5 Live CEs
+ 17 bonus CEs
🏅
CDCES & BC-ADM
Exam Prep + Renewal
📍
San Diego, CA
1.7 mi from airport
The field of diabetes care is expanding and evolving rapidly. This unique training conference will keep you on the cutting edge plus prepare you for certification exams. It also fulfills the Standards of Care renewal requirement. Join us for two days of intensive education that is fun and inspiring. Add on the optional Day 3 (Engaging the Disengaged), to complete your conference exeperience.
Coach Beverly and Diana Isaacs, PharmD, BC-ADM, CDCES co-lead an exciting day that brings the ADA and AACE Standards to life. Gain fresh insights, practical tools, and a deeper understanding of the latest in person-centered diabetes care. After attending, you will be empowered to share the latest in diabetes care with your colleagues and the people in your care.
Take your knowledge to the next level with this intensive deep-dive into insulin therapy, dosing and pattern management with Dr. Diana Isaacs. Next, stay for the diabetes tech show-and-tell as Diana demonstrates the specs of the latest pumps and sensors. After lunch, nutrition whiz Christine Craig, MS, RDN, CDCES expertly details the latest in MNT and provides real strategies on translating this content to your clinical practice. You will have a chance to put it all together as Coach Beverly leads you through a series of case studies that integrates content from Day 1 and Day 2.
On Saturday, join this exceptional day-long program led by William H. Polonsky, PhD, CDCES & Susan Guzman, PhD (Behavioral Diabetes Institute) that reveals psychosocial forces behind diabetes self-management — tools to break through resistance and inspire change.
Read more below
📜 Essentials
Registration
+ Printed Syllabus
$559.00
🌟 Deluxe
Essentials
+ ADA Standards Book
$589.00
🏆 Complete – Best Value!
Deluxe
+ ADCES Review Guide e-Book
$669.00
Transform how you engage patients with diabetes — master behavior change, reduce distress, and overcome medication hesitancy.
Why do so many patients know what they should do — but still struggle to do it?
The answer lies in the psychology of diabetes.
In this transformative full-day course, world-renowned experts William H. Polonsky, PhD, CDCES, and Susan Guzman, PhD, from the Behavioral Diabetes Institute reveal the hidden psychosocial forces that drive — or derail — diabetes self-management.
You’ll walk away with a completely new toolkit for breaking through patient resistance, dissolving medication hesitancy, and creating clinical encounters that actually inspire change!
For last week’s practice question, we quizzed participants on the best medication for HFpEF. 79% of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!
Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it by clicking here.
JL has T2DM, and heart failure with preserved ejection fraction (HFpEF). Is currently on Metformin 1000mg BID and empagliflozin 25mg daily. Their A1C is 8.1%.
Which agent should be added next, to provide maximum heart failure protection?
Answer A is correct. 79.19% chose this answer, “GLP-1 Receptor Agonist.” Great job, this is the best answer! For patients with heart failure and preserved ejection fraction, a GLP-1 RA is prioritized to preserve heart function, regardless of A1C.
Answer B is incorrect. 6.04% of you chose this answer, “Sulfonylurea (e.g., Glimepiride).” This is not the best answer. Sulfonylureas will lower blood glucose but will not provide the specific heart protective benefits required for this high-risk individual.
Answer C is incorrect. About 8.05% of respondents chose this: “DPP-4 inhibitor (e.g., Sitagliptin).” This is not the best answer. DPP-IVs not be a good choice, since they don’t have heart protective benefits, and alogliptin and saxagliptin can cause heart failure.
Finally, Answer D is incorrect. 6.71% chose this answer, “Basal insulin based on body weight.” This is not the best answer. While basal insulin will help lower blood glucose levels, it won’t help with heart failure.
We hope you appreciate this week’s rationale! Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!
Join us on June 11, 2026, at 11:30 am PST, for the 2026 webinar update
Beverly Thomassian, RN, MPH, CDCES, BC-ADM, brings extensive expertise in diabetes foot care, amputation prevention, and comprehensive health assessment.
What’s included:
Are you a healthcare professional providing diabetes care in an under-resourced community? Are you working toward earning your certification in diabetes education (CDCES or BC-ADM?)
If yes, please consider applying for our Bridge Scholarship, which covers the registration cost for the DiabetesEd Training Conference in San Diego, Oct 22-23, 2026 (value of $559). This program will provide you with the content needed to prepare for mastery-level diabetes certification and beyond!
Recipients will be awarded the Training Conference reg fee, including the live program, printed syllabus, 30+ CE’s, plus access to the online bonus courses for one year! Applications Due on July 20th, 2026
🌟Updated Schedule: ADA Boot Camp, Tech, MNT & More
Live in Beautiful San Diego – Oct 22-23, 2026
Re-Ignite your Passion & Prepare for Diabetes Certification Exams
🎓 Earn 30+ CEs: AMA PRA Category 1 Credits™, ACPE, ANCC, and CDR!
📅
2-Day Conference
Oct 22–23, 2026
⏱️
15.5 Live CEs
+ 17 bonus CEs
🏅
CDCES & BC-ADM
Exam Prep + Renewal
📍
San Diego, CA
1.7 mi from airport
The field of diabetes care is expanding and evolving rapidly. This unique training conference will keep you on the cutting edge plus prepare you for certification exams. It also fulfills the Standards of Care renewal requirement. Join us for two days of intensive education that is fun and inspiring. Add on the optional Day 3 (Engaging the Disengaged), to complete your conference exeperience.
Coach Beverly and Diana Isaacs, PharmD, BC-ADM, CDCES co-lead an exciting day that brings the ADA and AACE Standards to life. Gain fresh insights, practical tools, and a deeper understanding of the latest in person-centered diabetes care. After attending, you will be empowered to share the latest in diabetes care with your colleagues and the people in your care.
Take your knowledge to the next level with this intensive deep-dive into insulin therapy, dosing and pattern management with Dr. Diana Isaacs. Next, stay for the diabetes tech show-and-tell as Diana demonstrates the specs of the latest pumps and sensors. After lunch, nutrition whiz Christine Craig, MS, RDN, CDCES expertly details the latest in MNT and provides real strategies on translating this content to your clinical practice. You will have a chance to put it all together as Coach Beverly leads you through a series of case studies that integrates content from Day 1 and Day 2.
On Saturday, join this exceptional day-long program led by William H. Polonsky, PhD, CDCES & Susan Guzman, PhD (Behavioral Diabetes Institute) that reveals psychosocial forces behind diabetes self-management — tools to break through resistance and inspire change.
Read more below
📜 Essentials
Registration
+ Printed Syllabus
$559.00
🌟 Deluxe
Essentials
+ ADA Standards Book
$589.00
🏆 Complete – Best Value!
Deluxe
+ ADCES Review Guide e-Book
$669.00
Transform how you engage patients with diabetes — master behavior change, reduce distress, and overcome medication hesitancy.
Why do so many patients know what they should do — but still struggle to do it?
The answer lies in the psychology of diabetes.
In this transformative full-day course, world-renowned experts William H. Polonsky, PhD, CDCES, and Susan Guzman, PhD, from the Behavioral Diabetes Institute reveal the hidden psychosocial forces that drive — or derail — diabetes self-management.
You’ll walk away with a completely new toolkit for breaking through patient resistance, dissolving medication hesitancy, and creating clinical encounters that actually inspire change!
For last week’s practice question, we quizzed participants on A1C 7.4% & struggling with hypoglycemia. 83% of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!
Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it by clicking here.
A 16-year-old with Type 1 Diabetes uses a CGM and has a Time in Range (70-180 mg/dL) of 72%, but their GMI (Glucose Management Indicator) is 7.4% and they report frequent serious hypoglycemic episodes during the night at least twice a week.
What is the priority intervention?
Answer A is incorrect. 4.78% chose this answer, “Increase the TIR goal to more than 80% to lower the A1C.” Even though the A1C and GMI are above the target, this individual is experiencing frequent hypoglycemia. Increasing the TIR target to 80%, would increase the frequency of their already dangerous hypoglycemic episodes.
Answer B is incorrect. 4.78% of you chose this answer, “Lower the high-glucose alert setting to 150 mg/dL.” Lowering the high glucose alert won’t help prevent hypoglycemic events. It may instead cause alarm fatigue, since the alarm would sound when glucose levels were 150 or greater.
Answer C is incorrect. About 6.96% of respondents chose this: “Recommend a transition to a traditional finger-stick regimen.” We want to maintain the CGM so the individual is alerted to lows and can take immediate action.
Finally, Answer D is correct. 83.48% chose this answer, “Adjust basal rates to reduce Time Below Range (< 70 mg/dL).” You chose the best answer. Great Job! This best answer recognizes that basal rates are most likely causing hypoglycemia during the night. Reducing the basal rates will decrease the frequency of hypoglycemia. For safety, fix the “lows” is the priority before addressing glucose above target.
We hope you appreciate this week’s rationale! Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!
🌟Updated Schedule: ADA Boot Camp, Tech, MNT & More
Live in Beautiful San Diego – Oct 22-23, 2026
Re-Ignite your Passion & Prepare for Diabetes Certification Exams
🎓 Earn 30+ CEs: AMA PRA Category 1 Credits™, ACPE, ANCC, and CDR!
📅
2-Day Conference
Oct 22–23, 2026
⏱️
15.5 Live CEs
+ 17 bonus CEs
🏅
CDCES & BC-ADM
Exam Prep + Renewal
📍
San Diego, CA
1.7 mi from airport
The field of diabetes care is expanding and evolving rapidly. This unique training conference will keep you on the cutting edge plus prepare you for certification exams. It also fulfills the Standards of Care renewal requirement. Join us for two days of intensive education that is fun and inspiring. Add on the optional Day 3 (Engaging the Disengaged), to complete your conference exeperience.
Coach Beverly and Diana Isaacs, PharmD, BC-ADM, CDCES co-lead an exciting day that brings the ADA and AACE Standards to life. Gain fresh insights, practical tools, and a deeper understanding of the latest in person-centered diabetes care. After attending, you will be empowered to share the latest in diabetes care with your colleagues and the people in your care.
Take your knowledge to the next level with this intensive deep-dive into insulin therapy, dosing and pattern management with Dr. Diana Isaacs. Next, stay for the diabetes tech show-and-tell as Diana demonstrates the specs of the latest pumps and sensors. After lunch, nutrition whiz Christine Craig, MS, RDN, CDCES expertly details the latest in MNT and provides real strategies on translating this content to your clinical practice. You will have a chance to put it all together as Coach Beverly leads you through a series of case studies that integrates content from Day 1 and Day 2.
On Saturday, join this exceptional day-long program led by William H. Polonsky, PhD, CDCES & Susan Guzman, PhD (Behavioral Diabetes Institute) that reveals psychosocial forces behind diabetes self-management — tools to break through resistance and inspire change.
Read more below
📜 Essentials
Registration
+ Printed Syllabus
$559.00
🌟 Deluxe
Essentials
+ ADA Standards Book
$589.00
🏆 Complete – Best Value!
Deluxe
+ ADCES Review Guide e-Book
$669.00
Transform how you engage patients with diabetes — master behavior change, reduce distress, and overcome medication hesitancy.
Why do so many patients know what they should do — but still struggle to do it?
The answer lies in the psychology of diabetes.
In this transformative full-day course, world-renowned experts William H. Polonsky, PhD, CDCES, and Susan Guzman, PhD, from the Behavioral Diabetes Institute reveal the hidden psychosocial forces that drive — or derail — diabetes self-management.
You’ll walk away with a completely new toolkit for breaking through patient resistance, dissolving medication hesitancy, and creating clinical encounters that actually inspire change!